Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-24 @ 7:36 PM
NCT ID:
NCT04377503
Eligibility Criteria:
Inclusion Criteria:
Men and non-pregnant women over 18 years old COVID diagnosis confirmed by real time polymerase chain reaction (RT-PCR) Pao2 / FIO2 \<200 Laboratory: high sensitivity C reactive protein\> 5 mg / L; lactic dehydrogenase (LDH ) \> 245 U / l; Ferritin\> 300; D-dimer\> 1500; Interleukin-6\> 7.0 pg / ml.
Exclusion Criteria:
* Known sensitivity/Allergy to tocilizumab
* Active tuberculosis
* Pregnancy
* Individuals, in the opinion of the investigators where progression to death is imminent and inevitable in the next 24 hours
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04377503
Study Brief:
Protocol Section:
NCT04377503